GAM
BSX icon

Gould Asset Management’s Boston Scientific BSX Stock Holding History

Gould Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
10,415
+315
+3% +$17.1K 0.07% 123
2026
Q1 		$634K Buy
10,100
+100
+1% +$8K 0.11% 92
2025
Q4 		$954K Sell
10,000
-200
-2% -$19.6K 0.17% 68
2025
Q3 		$996K Hold
10,200
– – 0.18% 66
2025
Q2 		$1.1M Buy
+10,200
New +$1.03M 0.21% 55

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gould Asset Management's BSX Position: Q2 2026 in Review

Gould Asset Management increased its Boston Scientific (BSX) stake by 3.1% in Q2 2026, buying an estimated $17.1K and bringing the position to 10,415 shares worth $445K. The position accounts for 0.07% of the portfolio, ranked #123.

Gould Asset Management first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.1M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Gould Asset Management held 10,415 shares of Boston Scientific worth $445K as of Q2 2026.
  • Gould Asset Management bought 315 Boston Scientific shares in Q2 2026, an estimated $17.1K.
  • Boston Scientific made up 0.07% of Gould Asset Management's portfolio in Q2 2026, its #123 holding.
  • Gould Asset Management first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Gould Asset Management's Boston Scientific position peaked at $1.1M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gould Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.